RxDoctor Payments Data

John Reavey-Cantwell, MD

Neurological Surgery · Richmond, VANPI 1740363837

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $14,050 of the $16,888 with a category attached, or 83.2%. Stryker accounts for 98.1% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $11,737 and has fallen 96.2% since, to $450 in 2025.

$16,888in general payments, 2019–2025

Across 26 payments — averaging $649.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$17K
  • Silk Road Medical, Inc.$149
  • Medtronic$128
  • Cardiva Medical, Inc.$49
$31,306in research payments, 2019–2025

Across 5 payments — averaging $6261.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$31K

What the payments were for

  • Consulting fees$14,05083%
  • Travel & lodging$2,20613%
  • Food & beverage$6334%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker19$16,563
Silk Road Medical, Inc.3$149
Medtronic2$128
Cardiva Medical, Inc.2$49

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,888 in reported general payments places this provider in the 80th percentile of 156 neurological surgery providers in Virginia.

See all neurological surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$107,470
Medicare patients
117
Services billed
493

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate25$334

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →